
CyberKnife® patient plan verification with the SRS MapCHECK ‐ First clinical experience
S. Peters, et al
PO‐1385, ESTRO 2020
S. Peters, et al
PO‐1385, ESTRO 2020
L. Bai, et al., Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan, China
Radiation Physics and Chemistry 173 (2020) 108885
M. Rose, et al., Sun Nuclear Corporation
Med. Phys. 47 (7), July 2020, 3153-3164
Z. Ouyang, et al., Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, U.S.
J Appl Clin Med Phys 2020; 21:1: 62–68
S. Inui, et al., Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, JP
Radiat Oncol 15, 175 (2020)
S Ohira, et al., Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, JP
Medical Dosimetry 45 (2020) 85–91
G Kuzmin, et al
The Cleveland Clinic Foundation, Cleveland, OH, PO-GeP-M-187, AAPM 2020
E. Bossuyt, et al., Iridium Kankernetwerk, Radiation Oncology Department, Belgium
ESTRO 2020, PH-0050
E. Bossuyt, et al., Iridium Kankernetwerk, Radiation Oncology Department, Belgium
Physics and Imaging in Radiation Oncology 16 (2020) 113–129
E. Almond, et al., Queen's Hospital - Barking Havering and Redbridge Hospitals NHS Trust, Radiotherapy, UK
PO‐1398, ESTRO 2020
M. Fusella, et al
PO 1368, ESTRO 2020
M. Fusella, et al
PO-1768, ESTRO 2020
D. Nguyen, et al.
Physica Medica 80 (2020) 159–166
M.Gargett, et al., Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia
Physics and Imaging in Radiation Oncology, 14 (2020) 43-47
F. Ria, et al., Carl E. Ravin Advanced Imaging Labs, Duke University Health System, Durham, NC, U.S.
Med. Phys., 47 (1633-1639) (June 2015)
A. Haughey, et al., North West Cancer Centre, Western Health and Social Care Trust, N. Ireland
ICCR - MCMA 20019
NRC Report Number: IRS-1860r; 11-March-2014
Frédéric Tessier
National Research Council Canada, 2015
Frédéric Tessier
National Research Council Canada, 2015